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Vitamin B12 Bearing a Binaphthyl Moietyt 
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Teruhisa OHNO, and Takuya NISHIOKA 
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(Received July 3, 1992) 
Hydrophobic vitamin B12 derivatives bearing a chiral binaphthyl moiety, hexamethyl 7 1-decarboxy-7 1-[(R)-2'­
methoxy-l,l'-binaphthyl-2-carboxymethyl]cobyrinate perchlorate [B 12-BINAP(R)] and hexamethyl 7 1-decarboxy-
7 1-[(S)-2'-methoxy-1, l '-binaphtyl-2-carboxymethyl]cobyrinate perchlorate [B 12-BIN AP(S)], were prepared . from 
cyanocobalamin. These complexes were characterized by means of electronic and circular dichroism spectroscopy 
as well as by cyclic voltammetry in comparison with those data for a hydrophobic vitamin B 12 without a binaphthyl 
moiety. The enantioselective alkylation of hydrophobic vitamin B 12 derivatives at the /3-axial site was examined in 
methanol with various 3-bromo-2-methylpropionic esters by means of 1 H NMR spectroscopy. All the hydrophobic 
vitamin B 12 derivatives used here, the one bearing methoxycarbonyl groups as peripheral substituents without a 
binaphthyl moiety, B 12-BINAP(R), and B 12-BINAP(S), were found to bind (S)-2-methylpropionates more favorably 
than the corresponding R-enantiomers; the highest S-selectivity was observed with the latter two derivatives, 65% 
e.e. The cause of such S-enantioselectivity was discussed with attention to stereochemical configurations of the
peripheral substituents placed in the corrin ring.
Naturally occurring apoproteins are considered to 
provide water-lacking and hydrophobic microenviron­
ments for vitamin B12 1,2 l to enhance the coenzyme activity 
in various isomerization reactions,3,4 l in addition to their 
stereochemical functions to mediate the reactions. One 
of the efficient approaches to mimicking the catalytic 
functions of vitamin B12-dependent holoenzymes is to 
develop vitamin B12 derivatives which can be utilized 
under dehydrated and/ or hydrophobic conditions. In 
this regard, we have been dealing with hydrophobic 
vitamin B12 derivatives which have ester groups in place 
of the peripheral amide moieties of the naturally occur­
ring vitamin B12. 5-Bl 
Vitamin B12 derivatives and model compounds have 
been found to catalyze the reduction of alkyl halides, 1 4 l 
nitriles, 1 5 l a,,8-unsaturated carbonyl derivatives, 1 6 l and 
olefins. 1 7 l These reactions proceed via formation of 
intermediates involving a Co-C bond that is sub­
sequently cleaved and transformed into a C-H bond. 
On the other hand, one of the fascinating functions of 
naturally occurring vitamin B12 is referred to its 
potentiality as a chiral catalyst in asymmetric synthesis, 
since vitamin B12 creates a chiral reaction site provided 
by a corrin ring and peripheral substituents. In this 
regard, we became interested in the enantioselective 
alkylation of vitamin B12 derivatives. Meanwhile, 
Schrauzer et al. examined the asymmetric alkylation of 
cobalamin with DL-alanine in the presence of VJ+ and 
oxygen radicals, 18 l and obtained the alanine-bound 
cobalamin in a o/L alanine ratio of 56 to 44 mol% (refer 
to Eq. 1). They attributed such enantioselectivity to a 
specific stereochemical microenvironment provided on 
t Contribution No. 961 from This Department. Preliminary 
Communication; see Ref. 32. 
the ,8-axial site of the corrin ring, even though the effect 
is very small. Ogoshi et al. investigated the alkylation of 
cobalamin with the prochiral 1-acetyl-1-alkylcyclopro­
panes that induces an asymmetric center in the resulting 
alkyl ligands (refer to Eq. 2). However, such a struc­
tural framework of the corrin moiety does not achieve 
high enantioselectivity in nonenzymatic reactions. In 
this paper, we report on preparation and enantioselective 
alkylation of novel vitamin B12 derivatives. 
Experimental 
General Analyses and Measurements. Elemental analyses 
were preformed at the Microanalysis Center of Kyushu 
University. IR spectra were taken on a JASCO IR-810 
infrared spectrophotometer, while electronic absorption 
spectra were recorded on a Hitachi 220A or a Hitachi 340 
spectrophotometer. Circular dichroism (CD) spectra were 
recorded on a JASCO J-500C spectropolarimeter. 1 H NMR
spectra were taken on a Hitacl:ii R-1500, a Bruker AC-250P, 
and a Bruker AMX-500 spectrometer installed at the Center of 
Advanced Instrumental Analysis of Kyushu University. 
Assignments of NMR signals for the cobalt complexes were 
performed by means of the 2D NMR technique (H-H COSY). 
Cyclic voltammograms were obtained on an apparatus 
composed of a Hokuto Denko HA-501 potentiostat/ galvano­
stat and a Hokuto Denko HB-104 function generator. 
Materials. 3-Bromo-2-methylpropionic acid was obtained 
by reaction of methacrylic acid with hydrogen bromide in acetic 
acid: Yield 91%; bp 110-111 °C/ 1000 Pa; IR (neat) 3000 
(carboxylic OH) and 1710 cm-1 (carboxylic C=O); 60 MHz
1 H NMR (CDCb, TMS) «5=1.33 (3H, d, CH3), 2.90 (lH, m, 
CH), 3.50 (2H, m, CH2Br), and 10.97 (lH, s, C02H). Various 
3-bromo-2-methylpropionic esters were prepared by
esterification of 3-bromo-2-methylpropionic acid.
Methyl 3-Bromo-2-methylpropionate: Yield 90%; bp 72-
73 0 C/ 2500 Pa; IR (neat) 1740 cm-1 (ester C=O);_ 60 MHz 
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rH3 rco11 7 + H-y-CO£ 
rco l 7 + 
CH3 
DL-alanine (D-alanine)-cobalamin 
12%e.e. 
(1) 
(2) 
X = COCH3, Y = CH2CH3 : 24% e.e. 
X = COCH3, Y = CH2C6H5: 33% e.e. 
1H NMR (CDCb, TMS) <'l=l.28 (3H, d, CH3), 2.84 (IH, m, 
CH), 3.47 (2H, m, CH2Br), and 3.66 (3H, s, C02CH3). 
Ethyl 3-Bromo-2-methylpropionate: Yield 80%; bp 82-
85 ° C/ 2500�2700 Pa; IR (neat) 1740 cm-1 ( ester C=O); 
60 MHz 1H NMR(CDCb, TMS) <'l=l.28 (3H, t, CH2C!!3), 1.30 
(3H, d, CH3), 2.85 (IH, m, CH), 3.48 (2H, m, CH2Br), and 4.15 
(2H, q, C!!2CH3). 
Butyl 3-Bromo-2-methylpropionate: Yield 77%; bp 88-
90 0 C/ 1300 Pa; IR (neat) 1740 cm-1 (ester C=O); 60 MHz 
1H NMR (CDCb, TMS) <'l=0.50-1.90 (7H, m, CH2CH2CH3), 
1.29 (3H, d, CH3), 2.87 (IH, m, CH), 3.51 (2H, m, CH2Br), and 
4.15 (2H, t, CH2CH2CH2CH3). 
Octyl 3-Bromo-2-methylpropionate: Yield 79%; bp 120 ° C/ 
1000 Pa; IR (neat) 1740 cm-1 (ester C=O); 60 MHz 1H NMR 
(CDCb, TMS) <'l=0.64-1.93 [15H, m, (CH2)6CH3], 1.26 (3H, 
d, CH3), 2.84 (IH, m, CH), 3.50 (2H, m, CH2Br), and 4.08 [2H, 
t, CH2(CH2)6CH3]. 
Cyclohexyl 3-Bromo-2-methylpropionate: Yield 66%; bp 
122.5-123.5 ° Cf 1300 Pa; IR (neat) 1740 cm-1 ( ester C=O); 
60 MHz 1H NMR (CDCb, TMS) <'l=l.00-2.16 [lOH, m, 
(CH2)s], 1.27 (3H, d, CH3), 2.84 (IH, m, CH), 3.50 (2H, m, 
CH2Br), and 4.83 [lH, m, CH(cyclohexyl)]. 
Benzyl 3-Bromo-2-methylpropionate: Yield 83%; bp 
15I.0-152.0 ° C/ 1300 Pa; IR (neat) 1740 cm-1 (ester C=O); 
60 MHz 1H NMR (CDCb, TMS) <'l=l.30 (3H, d, CH3), 2.92 
(IH, m, CH), 3.50 (2H, m, CH2Br), 5.14 (2H, s, CH2Ph), and 
7.34 (5H, s, phenyl). 
Phenethyl 3-Bromo-2-methylpropionate: Yield 69%; bp 
135 ° Cf 1000 Pa; IR (neat) 1740 cm-1 ( ester C=O); 60 MHz 
1H NMR (CDCb, TMS) <'l=l.22 (3H, d, CH3), 2.94 (2H, t, 
CH2CH2Ph), 2.94 (IH, m, CH), 3.45 (2H, m, CH2Br), 4.33 (2H, 
t, CH2CH2Ph), and 7.25 (5H, s, phenyl). 
Neopentyl 3-Bromo-2-methylpropionate: Yield 68%; bp 
105 ° Cf 1000 Pa; IR (neat) 1740 cm-1 ( ester C=O); 60 MHz 
1H NMR (CDCb, TMS) <'l=0.96 [9H, s, CH2(CH3)3], 1.30 (3H, 
d, CH3), 2.94 (IH, m, CH), 3,56 (2H, m, CH2Br), and 3.83 [2H, 
s, CH2(CH3)3]. 
All the 3-bromo-2-methylpropionates were confirmed to be 
sufficiently pure by GLC before use. Cyanocobalamin was a 
donation of Nippon Oil Company (Tokyo, Japan). Prepa­
ration of heptamethyl cobyrinate perchlorate (B12-ESTER)20) 
has been described previously.5 1 Hydrophobic vitamin B12 
derivatives having a binaphthyl group placed at one of the 
peripheral sites were prepared by following the reaction steps 
shown in Scheme 1. 
Cyanocobalamin-c,8-lacfone (1). This compound was 
prepared by reaction of cyanocobalamin (2.0 g, I.5xl0-3 mol) 
with N-bromosuccinimide (NBS) (0.32 g, l.8Xl0-3 mol) in 
aqueous acetic acid (500 mL, 0.5 mol dm-3) after a reported
procedure:21 ) Yield 1.7 g (84%); Amax(CH30H) 279 (e 8.06Xl03), 
Cyanocobalamin NBS 1 
CH30H-H2S04 KCN NaBH4 KCN 3 
3 
�COCI 
OCH3 
I 
8 
COCI g 
OCH3 
4 
N2, Reflux 
HCI04 6 
NaBH4 HCI04 B12-BINAP(R) 
7 
Scheme 1. 
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306 (8.77Xl03), 321 (7.92Xl03), 359 (2.68Xl04), 410 (3.33Xl03), 
520 (7.56Xl03), and 551 nm (8.06Xl03); CD (CH30H) ll.e=-13 
(251 nm), -4.0 (309 nm), +2.2 (328 nm), -12 (355 nm), +12 
(427 nm), and -1.6 deg cm2 dmo1-1 (555 nm); IR (KBr) 1785
(lactone C=O) and 1655 cm-1 (amide C=O). Found: C, 54.97;
H, 6.23; N, 13.37%. Calcd for C63HssCoN1301s· H20: C, 55.13; 
H, 6.39; N, 13.27%. 
Hexamethyl Coa,CoP.Dicyano-71-de( carboxymethyl)-71 , 
72-dihydro-72-oxofuro[3,2-g]cobyrinate (2). Compound 1 
(4.0 g, 3.0xlQ-3 mol) in dry methanol (400 mL) was mixed with 
cold coned sulfuric acid (40 mL) and dry methanol (200 mL). 
The solution was refluxed for 120 h in the dark. The reaction 
mixture was concentrated to ca. 150 mL, diluted with cold 
water (300 mL), and quickly neutralized with sodium carbonate 
powder. After an aqueous solution (20 mL) of potassium 
cyanide (5.0 g, 7.7x10-2 mol) being added, the reaction mixture 
was extracted with carbon tetrachloride (150 mLX3). The 
extract was dried over sodium sulfate and evaporated to 
dryness at room temperature. The residue was dissolved in 
benzene, and the product was recovered by reprecipitation with 
hexane as a purple powder: Yield 2.5 g (84%); Amax(CH30H) 
275 (e 9.1Xl03), 314 (8.3Xl03), 366 (l.8Xl04), 414 (8.3Xl03), 545 
(7.9Xl03), and 586 nm (8.9X103); IR (KBr) 2130 (C=N), 1785 
(lactone C=O), and 1735 cm-1 (ester C=O); CD (CH30H)
!!..e=+0.27 (286.4 nm), +5.68 (304.0 nm), -2.01 (324.4 nm), 
-8.68 (346.4 nm), + 15.3 (391.2 nm), and -3.43 deg cm2 
dmo1-1 (577.6 nm).
Hexamethyl Coa,CoP.Dicyano-71-decarboxy-71-(bydroxy­
methyl)cobyrinate (3). Distilled water (50 mL) was added to 
compound 2 (500 mg, 4.7x10-4 mol) dissolved in methanol
(150 mL). The solution was deoxygenated by bubbling 
nitrogen gas through it for 30 min, and treated with sodium 
tetrahydroborate (1.0 g, 2.6x10-2 mol) with vigorous stirring 
2 :X=Y=CN, 
� M�-/ C02CH3 
4 :X=Y=CN, 
R, = �C02CH2-
roOCH3 
B12·ESTER : x = v = none, 
B12·BINAP(R) : x = v = none, 
B12·BINAP(S): X=Y=none, 
3 :X=Y=CN, 
R,= 
for 5 min. An excess amount of sodium tetrahydroborate was 
decomposed by adding aqueous perchloric acid [60% (w/w), 
5 mL] carefully to the mixture. The resulting cobalt complex 
was extracted with dichloromethane (50 mLX3) and washed 
with distilled water and saturated aqueous sodium carbonate. 
After the dichloromethane solution was shaken with 20 mL of 
aqueous potassium cyanide (3.0 g, 4.6x10-2 mol), the layers 
separated. The organic layer was dried over sodium sulfate 
and evaporated to dryness. The residue was purified by TLC 
on silica gel (Kiesel gel 60, Merck) with dichloromethane­
methanol (95 : 5 v/v) containing 0.05% (w/w) potassium 
cyanide. The second purple fraction was collected, dissolved 
in methanol, and evaporated to dryness. The residue was 
dissolved in benzene, and the product was recovered by 
reprecipitation with hexane as a purple powder: Yield 160 mg 
(32%); Amax(CH30H) 280 (e 8.6Xl03), 316 (8.1Xl03), 368 
(2.3Xl04), 548 (7.5Xl03), and 587 nm (9.0X103); IR (KBr) 2130 
(C=N) and 1735 cm-1 (ester C=O); CD (CH30H) l'l.e=-0.36
(286.0 nm), -5.77 (304.4 nni), +0.47 (320.4 nm), -10.9 
(346.0 nm), + 15.3 (394.8 nm), and -4.12 deg cm2 dmoI-1
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(580.4 nm). Found: C, 57.95; H, 6.57; N, 7.61%. Calcd for 
Cs3H73CoN6014·H20: C, 58.12; H, 6.90; N, 7.67%. 
Hexamethyl Coa,CoP-Dicyano-71-decarboxy-71-[(R)-2' -
methoxy-1,1 '-binaphthyl-2-carboxymethyl]cobyrinate ( 4). 
(R)-2' -Methoxy-1, l'-binaphthyl-2-carbonyl chloride (8)22) 
(400 mg, I.2xI0-3 mol), triethylamine (0.5 mL), and 4-
dimethylaminopyridine (10 mg) were added to compound 3 
(200 mg, l.9XI0-4 mol) dissolved in dry dichloromethane 
(20 mL) under nitrogen atmosphere. The solution was stirred 
for 12 h at room temperature and then refluxed over 12 h. 
After the reaction mixture was washed with aqueous 
hydrochloric acid (2 mol dm-3, 50 mLX2) and distilled water 
(50 mLX3), the unreacted binaphthylderivative was removed 
by column chromatography (Kiesel gel 60, CH2Ch). The 
product was purified by TLC on silica gel (Kiesel gel 60) with 
dichloromethane-methanol (94 : 6 v / v) containing 0.05% 
(w/w) potassium cyanide. The second purple fraction was 
collected, dissolved in methanol, and evaporated to dryness. 
The residue was dissolved in benzene, and the product was 
recovered by reprecipitation with hexane as a purple powder: 
Yield 173 mg (67%); Amax(CH30H) 282 (s 2.3XI04), 369 
(2.9Xl04), 515 (6.2Xl03), 526 (9.7Xl03), 588 nm (l.2XI04); IR 
(KBr) 2125 (C=N), 1735 (ester C=O), and 770 cm-1 (aromatic
CH); CD (CH30H) Ac=+ 107 (225.6 nm), -137 (239.4 nm), 
+14.9 (284.5 nm), -5.7 (305.6 nm), +3.9 (326.2 nm), -8.8
(348.5 nm), + 14.4 (395.5 nm), and -0.83 deg cm2 dmo1-1
(580.6 nm). Found: C, 64.60; H, 6.18; N, 5.87%. Calcd for
C1sHs1CoN6016: C, 64.93; H, 6.32; N,6.06%.
Hexamethyl Coa,CoP-Dicyano-71-decarboxy-71-[(S)-2'­
methoxy-1,1' -binaphthyl-2-carboxymethy l]cobyrinate ( 5). 
This compound was prepared with (S)-2'-methoxy­
l,l'-binaphthyl-2-carbonyl chloride (9)22) in place of 8 after a 
method identical with that employed for the preparation of 4: 
Yield 66%; Amax(CH30H) 282 (s 2.3Xl04), 369 (2.9XI04), 515 
(6.2Xl03), 526 (9.7Xl03), and 588 nm (l.2Xl04); IR (KBr) 2125 
(C=N), 1735 (ester C=O), and 770 cm-1 (aromatic CH); CD
(CH30H) As=-91 (225.6 nm), +200 (239.4 nm), -9.8 (279.7 nm), 
-IO.I (290.4 nm), -8.4 (305.6 nm), -10.9 (345.9 nm), +15.1
(395.5 nm), and -0.83 deg cm2 dmol-1 (580.6 nm). Found: C,
64.42; H, 6.14; N, 5.88%. Calcd for C1sHs1CoN6016: C, 64.93;
H, 6.32; N, 6.06%.
Hexamethyl Coa,Cop-Cyanoaqua-71-decarboxy-71-[(R)-2' -
methoxy-1,1' -binaphthyl-2-carboxymethyl]cobyrinate Per­
chlorate (6). A purple solution of 4 (90 mg, 6.4XI0-5 mol)
dissolved in dichloromethane (50 mL) was shaken with 30% 
(w / w) aqueous perchloric acid (80 mL). The orange dichloro­
methane layer was separated, washed with distilled water 
(100 mLX2), dried over sodium sulfate, and evaporated to 
dryness at room temperature. The residue was dissolved in 
benzene, and the product was recovered by reprecipitation with 
hexane as an orange powder: Yield 100 mg (95%); Amax 
(CH30H) 275 (c 1.32Xl04), 296 (l.05XI04), 354 (l.76Xl04), 403 
(3.14Xl03), 494 (5.80XI03), and 528 nm (5.62Xl03); IR (KBr) 
2130 (C=N), 1735 (ester C=O), and 1120 and 630 cm-1 (Cl04-);
CD (CH30H) Ac=+97.7 (228.6 nm), -126 (239.8 nm), + 10.4 
(289.6 nm), +3.13 (329.6 nm), +5.41 (427.2 nm), and -3.01 
deg cm2 dmo1-1 (487.2 nm). Found: C, 59.56; H, 5.82; N,
5.04%. Calcd for C14Hs9ClC0Ns021·0.5H20: C, 59.73; H, 
6.10; N, 4.71%. 
Hexamethyl Coa,Cop..Cyanoaqua-71-decarboxy-71-[(S)-2' -
methoxy-1,1' -binaphthyl-2-carboxymethyl]cobyrinate Per­
chlorate (7). This compound was prepared after a method 
identical with that employed for the preparation of 6: Yield 
95%; Amax(CH30H) 275 (s 1.32XI04), 296 (1.05Xl04), 354 
(l.76XI04), 403 (3.14Xl03), 494 (5.80XI03), and 528 nm 
(5.62Xl03); IR (KBr) 2130 (C=N), 1735 (ester C=O), and 1120 
and 630 cm-1 (Cl04-); CD (CH30H) Ac=-98.6 (226.4 nm),
+ 150 (239.8 nm), -11.9 (289.6 nm), -7.0 (336 nm), +2.63
(353.2 nm), +10.8 (425.6 nm), -6.02 (487.2 nm), and +I.61
deg cm2 dmo1-1 (541.2 nm). Found: C, 59.44; H, 5.92; N,
4.72%. Calcd for C14Hs9ClC0Ns021·H20: C, 59.38; H, 6.13;
N, 4.68%.
Hexamethyl 71-Decarboxy-71-[(R)-2'-methoxy-1,1' -binaph­
thyl-2-carboxymethyl]cobyrinate Perchlorate [B12-BINAP­
(R)]. A methanol solution (100 mL) of compound 6 (100 mg, 
6.7xI0-5 mol) was deoxygenated by bubbling nitrogen gas
through it for 30 min, and sodium tetrahydroborate (100 mg, 
2.6xI0-3 mol) was added to the deoxygenated solution with 
vigorous stirring under nitrogen atmosphere. When the 
solution turned dark green, 60% (w / w) aqueous perchloric acid 
(3 mL) was added carefully to it in order to decompose an 
excess sodium tetrahydroborate and to convert the Co1 species 
into the corresponding Con species. The resulting cobalt 
complex was extracted with dichloromethane (25 mLX2). 
The extract was washed with distilled water, dried over sodium 
sulfate, and evaporated to dryness at room temperature. The 
residue was dissolved in benzene, and the product was 
recovered by reprecipitation with hexane as a brown powder: 
Yield 70 mg (72%); Amax(CH2Ch) 266, 286, 298, 315, 400, and 
468 nm; IR (KBr) 1735 (ester C=O), and 1120 and 630 cm-1
(Cl04-); CD (CH30H) Ac=+ 102 (226.2 nm), -133 (239.0 nm), 
+17.4 (292.8 nm), +17.4 (315.2 nm), -3.26 (426.4 nm), and
+I.57 deg cm2 dmoI-1 (460.0 nm). Found: C, 59.19; H, 6.19;
N, 4.41%. Calcd for C73H37ClCoN4020·2H20: C, 59.61; H,
6.24; N, 3.81%.
Hexamethyl 71-Decarboxy-71-[(S)-2' -methoxy-1,1' -binaph­
thyl-2-carboxymethyl]cobyrinate Perchlorate [B12-BINAP­
(S)]. This compound was prepared after a method identical 
with that employed for the preparation of B12-BINAP(R): 
Yield 62%; Amax(CH2Ch) 266 (s 2.0XI04), 286 (l.9XI04), 298 
(1.9Xl04), 315 (2.0XI04), 400 (5.8XI03), and 468 nm (9.0XI03); 
IR (KBr) 1735 (ester C=O), and 1120 and 630 cm-1 (Cl04-); CD
(CH30H) Ac=-85.9 (225.6 nm), + 138 (239.4 nm), -10.04 
(264.0 nm), -10.3 (281.2 nm), + 12.0 (314.0 nm), -3. 78 ( 423.6 nm), 
and + 1.06 deg cm2 dmol-1 ( 460.8 nm).
Cyclic Voltammetry. An electrochemical cell similar to that 
reported in literature23) was used and equipped with platinum 
wire of 0.5 mm diameter as working and auxiliary electrodes. 
A saturated calomel electrode (SCE) was served as a reference 
which was separated from a bulk electrolyte solution by a salt 
bridge prepared with 1,2 : 4,5-0-dibenzylidene-o-glucitol24 ) and 
an organic solvent containing tetrabutylammonium perchlo­
rate (TBAP, 5.0xI0-2 mol dm-3). Acetonitrile, acetone, N,N­
dimethylformamide (DMF), and dimethyl sulfoxide (DMSO) 
were used as media for cyclic voltammetry. An organic 
solution containing a hydrophobic vitamin B12 derivative and 
TBAP were deaerated prior to each measurement, and the cell 
interior was maintained under argon atmosphere throughout 
each measurement. All the measurements were carried out at 
20±2 ° C, and the scan rate was varied in a range from 50 
through 500 m V s-1. Half-wave potentials (E112) and anodic
and cathodic currents were evaluated according to the method 
described previously.25)
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Derivatives. Alkylated complexes were prepared by reaction 
of the hydrophobic vitamin B12 derivatives in the Co(I) state 
with various 3-bromo-2-methylpropionates in a manner similar 
to that described previously, 8l and identified by electronic and 1 H NMR spectroscopy. Preparation of the methyl 2-methyl­
propionate adduct of B12-ESTER is described below as a 
representative example. 
A methanol solution (50 mL) of B12-ESTER (50 mg, 4.4X 
10-s mol) was deoxygenated by bubbling nitrogen gas through
it for 30 min, and sodium tetrahydroborate (100 mg, 2.6X
10-3 mol) was added to the deoxygenated solution with 
vigorous stirring under nitrogen atmosphere. The following 
operations were carried out in the dark. When the solution 
turned dark green, methyl 3-bromo-2-methylpropionate 
(500 mg, 2.8XlQ-3 mol) was added to it. The resulting solu­
tion was stirred for 7 min at room temperature, and 60% 
(w/w) aqueous perchloric acid (3 mL) was added carefully to 
it in order to decompose an excess sodium tetrahydroborate. 
The resulting mixture was extracted with dichloromethane 
(25 mLX3), and the extract was washed with distilled water. 
After being dried over sodium sulfate, the extract was evapo­
rated to dryness at room temperature. The product was 
purified by gel-filtration chromatography on a column of 
Sephadex LH-20 with methanol as eluent in the dark. The 
first brown fraction was collected and evaporated to dryness at 
room temperature under reduced pressure. The residue was 
dissolved in benzene, and the product was recovered by 
reprecipitation with hexane as a brown powder: Yield 44 mg 
(67%); Amax(CH2Ch) 264 (e 2.22Xl04), 302 (2.24Xl04), 378 
(7.86X103), and 456 nm (8.51X103); IR (KBr) 1730 (ester C=O), 
and 1100 and 620 cm-1 (ClQ4-). Found: C, 54.43; H, 6.52; N,
4.56%. Calcd for Cs1Hs4ClCoN4021: C, 54.52; H, 6.74; N, 
4.46%. 
Although both Coa- and Cofi-axial ligand isomers are 
expected to be formed, the Coa-axial ligand isomer is much less 
likely formed because of remarkable steric hindrance between 
the angular methyl group at C( 1) of the corrin ring and the axial 
ligand moiety bound to the nuclear cobalt. The alkylated 
complex prepared by the present method was confirmed to be 
the Cofi-bound isomer on the basis of ! H NMR spectroscopy. 26l
The enantioselective alkylation for the hydrophobic vitamin 
B12 derivatives was examined by 500 MHz 1H NMR spectro­
scopy, (+)-methyl (R)-3-bromo-2-methylpropionate and (-)­
methyl (S)-3-bromo-2-methylpropionate (both from Aldrich 
Chemical Co., U.S.A.) being adopted as reference substrates. 
The enantioselectivity in alkylation was evaluated from 
1H NMR signal areas by the aid of a NMRl ™ software (New
Methods Research, Inc., U.S.A.) on a DEC 5000/200PX 
workstation . 
Results and Discussion 
Electronic and Circular Dichroism Spectra of Hydro­
phobic Vitamin B12 Bearing a Binaphthyl Moiety. 
Electronic and CD spectra of 4 and 5 in methanol are 
shown in Fig. 1. The electronic spectra of 4 and 5 with 
(R)- and (S)-binaphthyl moieties, respectively, are 
identical to each other, exhibiting a strong absorption 
band at 282 nm as caused by the binaphthyl moiety. 
These spectra are quite similar to that for heptamethyl 
dicyanocobyrinate, which does not bear a binaphthyl 
moiety, in the 350-700 nm range. 27l Such observations 
clearly indicate that the corrin ring hardly interacts 
electronically with the peripheral binaphthyl group. 
The CD spectra of 4 and 5 are quite similar to each 
other in the 350-700 nm range, and this spectral pattern 
is comparable to that of cyanocobalamin in the same 
wavelength range. 28l The strong CD bands arising from 
the chiral binaphthyl moiety are observed in the 200-
280 nm range; 4 and 5 exhibit spectral patterns nearly 
symmetrical with each other in this wavelength range. 
On the basis of theoretical calculation of the CD spectra 
for 2,2'-disubstituted-1,1'-binaphthalenes, the Cotton 
effects are expected to appear in the 230 nm range, as 
derived from the �Bb transition of the naphthalene 
chromophores. 29l In addition, the intensity of the 
Cotton effects derived from the 1Bb transition was
revealed to decrease with increase of the dihedral angle 
between the naphthalenes of the 1, l '-binaphthalene 
skeleton. 29l Since the intensity of Cotton effects in the 
230 nm range for both 4 and 5 is similar to that for 
binaphthalenes 8 and 9, a significant steric interaction 
does not seem to be operative between the corrin ring and 
the binaphthyl moiety. 
Redox Behavior of Hydrophobic Vitamin B12 Bearing 
a Binaphthyl Moiety. Redox behavior of B12-BINAP­
(R) and B12-BINAP(S) in various organic solvents, such 
as acetonitrile, acetone, DMF, and DMSO, was 
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Fig. 1. Electronic and CD spectra of B12-BINAP(R) 
and B12-BINAP(S) in methanol: solid line, B12-
BINAP(S); broken line, B12-BINAP(R). The �e 
values are given in one tenth of real values for the 200-
265 nm range. 
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Table 1. Redox Potentials for B12-BINAP and B12-ESTER in Nonaqueous Mediaa) 
Mediumbl 
CH3CN 
CH3COCH3 
DMF 
DMSO 
14.1 
17.0 
26.6 
29.8 
0.460 
0.355 
0.404 
0.444 
E1;2 vs. SCE/V 
Co(III) / Co(II) Co(II) / Co(I) 
+0.57 (+0.45)0) 
+0.72 (+0.77)0) 
+0.38 (+0.40)°) 
+0.32 (+0.30)0) 
-0.54 (-0.64)°) 
-0.45 (-0.53)0) 
-0.58 (-0.61)0) 
-0.62 (-0.64)0) 
a) Measured at 20±2 ° C; scan rate, 100 mV s-1. b) Abbreviations: DMF, N,N-dimethylformamide;
DMSO, dimethyl sulfoxide. c) Donor number of a solvent; refer to Ref. 30. d) Solvent polarity
parameter; refer to Ref. 31. e) A redox potential (E1;2) for B12-ESTER is given in parentheses; refer to
Ref. 6.
examined by means of cyclic voltammetry. A cyclic 
voltammogram of B12-BINAP(R) in DMSO is shown in 
Fig. 2 as a typical example, whereas the identical 
voltammogram was observed for B12-BINAP(S). The 
Co(III) / Co(II) and Co(II) / Co(I) red ox potentials are 
summarized in Table I. 
The Co(III) / Co(II) and Co(II) / Co(I) red ox couples 
for B12-BINAP in acetonitrile [solvent basicity DN, 
14.1]30) were observed at +0.57 and -0.54 V vs. SCE, 
respectively; the corresponding redox potentials (E1;2) 
for B12-ESTER were found at +0.45 and -0.64 V vs. 
SCE, respectively.6) The redox potentials for B12-
BINAP(R) and B12-BINAP(S) were shifted to an anodic 
side by ca. I 00 m V relative to the corresponding 
potentials for B12-ESTER. A similar tendency, though 
to a less extent, was observed for those potentials 
observed in acetone as listed in Table I. Therefore, the 
binaphthyl group furnishes a specific microenvironmen­
tal effect on the redox behavior of the nuclear cobalt 
when B12-BINAP is treated in organic solvents of lower 
basicity. 
On the other hand, the redox potentials for B12-
ESTER and B12-BINAP in DMF, a solvent of high 
basicity (DN=26.6), 30) are quite similar to each other; the 
Co(III) / Co(II) and Co(II) / Co(I) red ox couples for B12-
BIN AP in DMF were observed at +0.38 and -0.58 V vs. 
SCE, respectively, while the corresponding redox 
potentials for B12-ESTER were at +0.40 and -0.61 V vs. 
SCE, respectively.6) A similar tendency was observed 
for those potentials measured in DMSO (DN=29.8).30) 
The solvent basicity is related to the axial ligation ability 
of solvent molecules; a sufficiently basic solvent tends to 
coordinate to the nuclear cobalt of a hydrophobic 
vitamin B12 derivative. Under such circumstances, the 
binaphthyl moiety of B12-BINAP does not give out any 
meaningful microenvironmental effect on the redox 
behavior of the nuclear cobalt, and the redox potentials 
are primarily subjected to change by the solvent nature. 
Enantioselective Alkylation of Hydrophobic Vitamin 
B12 Derivatives. The enantioselective alkylation of B12-
ESTER, B12-BINAP(R), and B12-BINAP(S) was ex­
amined by 500 MHz 1H NMR spectroscopy, (+)-methyl
(R)-3-bromo-2-methylpropionate and (-)-methyl (S)-3-
bromo-2-methylpropionate (both from Aldrich 
Chemical Co., U.S.A.) being adopted as reference 
-1.0
0.5µA 
+ 
-0.5 0 
(E vs. SCE) / V 
+0.5
Fig. 2. Cyclic voltammogram of B12-BINAP(R) (7.2X 
10-4 mo! dm-3) in DMSO containing 5.0x10-2 mo!
dm-3 TBAP at 20±2 ° C; scan rate, 50 mV s-1.
Table 2. Assignments of 1 H NMR Signals for an
Alkyl Moiety Placed at the Axial Site of 
B12-ESTER in CDCh at 25 ° C 
o/ppmbl 
Assignment") Splitting ------------­
R-Configuration S-Configuration 
A 
B 
C 
Multiplet 
Doublet 
Singlet 
-0.68
0.26
3.35
-0.50
0.43
3.40
a) Refer to Eq. 3. b) Tetramethylsilane as an internal
reference.
HXCH3 � 
( �C02CH3 ----­
Br 
(3) 
substrates. The major proton signals for the reference 
alkyl moieties placed at the /3-axial site of the 
hydrophobic vitamin B12 were assigned as listed in Table 
2 (refer to Eq. 3). All the signals for the alkyl moiety 
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Table 3. Enantioselectivity for the Reaction of Hydrophobic Vitamin B12 Derivatives with 
Various 3-Bromo-2-methylpropionic Esters in Methanol at Room Temperature•) 
R2 in 3-bromo-2-methylpropionatebl Vitamin B12 derivative Yieldc) /% 
Selectivity 
% e.e. Configuration 
CH3 B12-ESTER 67 34 s 
C2Hs B12-ESTER 63 44 s 
C4H9 B12-ESTER 79 44 s 
CsHn B12-ESTER 60 51 s 
(CH3)3CCH2 B12-ESTER 66 45 s 
Cyclohexyl B12-ESTER 86 55 s 
C6HsCH2CH2 B12-ESTER 66 47 s 
C6HsCH2 B12-ESTER 68 49 s 
C6HsCH2 B12-BINAP(R) 60 64 s 
C6HsCH2 B12-BINAP(S) 54 65 s 
a) Each reaction was carried out at a 1: 5 molar ratio of a vitamin B12 derivative to a 3-bromo-2-methylpropionic
ester; a vitamin B12 derivative, 50 mg. b) Refer to Eq. 4. c) Isolated yield, as purified by gel-filtration
chromatography on a column of Sephadex LH-20 with methanol as eluent in the dark; crude yield, above 80%.
(4) 
bound to the nuclear cobalt showed significant up-field 
shifts due to a shielding effect given by the corrin ring. 
The result indicates that the proton signals for the alkyl 
moiety with R-configuration appear in upper field ranges 
relative to those for the alkyl moiety with S-con­
figuration. The enantioselectivity in alkylation was 
evaluated from the 1 H NMR signal areas. When the
racemic 3-bromo-2-methylpropinate was used, the 
reactivity of the S-enantiomer in the alkylation prevails 
over that of the corresponding R-enantiomer. The 
enantioselectivity data for the formation of other 
alkylated complexes were evaluated by the identical 
method as summarized in Table 3.32 ) 
The alkylation study reveals the following facts with 
respect to enantioselectivity (refer to Eq. 4 and Table 3). 
(i) B12-ESTER affords the alkylated complexes by
reaction with 3-bromo-2-methylpropionates in favor of
binding S-enantiomers, and the selectivity is enhanced as
the bulkiness of an R2 group increases. (ii) The highest
enantioselectivity is attained for the reaction of B12-
ESTER with a 3-bromo-2-methylpropionate bearing a
cyclohexyl ester group, 55% e.e. (iii)The hydrophobic
vitamin B12 derivatives having a binaphthyl group, B12-
BINAP(R) and B12-BINAP(S), exhibit higher selectivity
toward an (S)-3-bromo-2-methylpropionate than the
simple hydrophobic vitamin B12, B12-ESTER, for the
reaction with an alkyl bromide bearing a benzyl ester
group, 65% e.e. This is the highest enantioselectivity in
the alkylation so far observed for vitamin B12-related
compounds. However, both B12-BINAP(R) and B12-
BINAP(S) having (R)- and (S)-binaphthyl groups,
respectively, undergo substitution at the /3-axial site with
the S-enantiomer more preferably than the R-
enantiomer at a comparable enantioselectivity. This 
seems to be caused by a conformational phenomenon 
that allows the binaphthyl group to rotate freely around 
the chain placed at the c-site of ring B. The results 
indicate that the stereoselectivity in the course of 
alkylation is apparently originated from a stereospecific 
arrangement of the bulky peripheral substituents placed 
around the corrin ring and not from the chiral nature of 
the specific peripheral substituent. 
We examined stereochemical arrangements of (R)­
and (S)-2-methylpropionate moieties bound to vitamin 
B12 in the light of X-ray crystal structures obtained for 
adenosylcobalamin and 2,3-dihydroxypropylcobal­
amin. 33, 34 ) A top view of the /3-site of cobalamin, show­
ing the corrin ring and the peripheral side chains at /3-site 
based on X-ray analysis is illustrated in Fig. 3(a). The 
peripheral substituents of cobalamin placed in rings A, B, 
C, and D are shown with shaded circles in Fig. 3(b ), in 
consideration of their effective bulkiness toward an alkyl 
moiety bound to the nuclear cobalt. According to the 
X-ray structural data for the above alkylated co balamins,
the most bulky group placed on the /3-carbon atom of the
alkyl moiety is directed toward a space intervening
between rings C and D. In consideration of such a
stereochemical state of affairs, (S)- and (R)-2-methyl­
propionate must be bound to the nuclear cobalt with
their 3-carbon atoms as illustrated in Figs. 3(c) and 3(d),
respectively, so that the steric hindrance between the
alkyl moiety and the peripheral substituents of
cobalamin is minimized. The stereochemical con­
figuration of the R-enantiomer shown in Fig. 3( d) seems
to be energetically less favorable than that of the S­
enantiomer shown in Fig. 3( c ), because a significant steric
interaction would be expected between the 2-methyl
group of the alkyl ligand and ring D. An alternative
configuration for the R-enantiomer is illustrated in Fig.
3(e). However, B12-BINAP, which bears a bulky
binaphthyl group at the peripheral site of ring B, must
give out a marked steric hindrance effect on the
carboxylic ester group (C02R). On this ground, the
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Fig. 3. Top views of cobalamin and its alkylated complex on the {3-site: (a) and (b), structural 
representation of cobalamin based on X-ray analysis; (c), structural representation of 
cobalamin with an axial ligand of S-configuration; (d) and (e), structural representation of 
cobalamin with an axial ligand of R-configuration. Shaded circles indicate the peripheral 
substituents in their effective bulkiness toward the axial ligand. 
stereochemical configuration of the R-enantiomer given 
in Fig. 3(e) turns out to be much less favorable than that 
shown in Fig. 3{d), and even can be excluded. As a 
consequence, the S-enantioselectivity in alkylation of 
B12-ESTER becomes enhanced as the effective bulkiness 
of an carboxylic ester group placed in an alkyl ligand 
increases. The S-enantioselectivity is ' even more 
pronounced in the alkylation of B12-BINAP due to the 
marked steric effect generated by the binaphthyl moiety 
introduced into ring B. 
In conclusion, the enantioselectivity in alkylation of 
the hydrophobic vitamin B12 having a binaphthyl group 
is superior to that of the simple hydrophobic vitamin B12. 
This means that the peripheral substituents of B12-
BINAP construct an effective chiral microenvironment 
for recognition of the S-enantiomer. 
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